Clinical Trial Update: Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma

View source ↗

Summary

This document updates the status of a clinical trial evaluating Selinexor (Nexpovio) in relapsed or refractory multiple myeloma, indicating the study is active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Nexpovio (Selinexor)
• Velcade (bortezomib)

Snippet

Sponsor: iOMEDICO AG | Conditions: Multiple Myeloma | Status: ACTIVE_NOT_RECRUITING